Autosomal dominant – Gain of function mutations Flashcards

1
Q

what is a hypermorph?

A

an allele that produces an increase in quantity or activity of its product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a Neomorph?

A

an allele with a novel activity or product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the common mechanism of GOF mutations at the cellular level?

A

Often a control or signalling system behaving aberrantly; signalling when it should not, or failing to switch a process off when it should

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Example of a product acquiring a novel function?

A

BCR-ABL1 translocation in chronic myeloid leukaemia (CML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

examples of some GOF mutations:

A

Overexpression PMP22 CMT
Receptor permanently on GNAS McCune-Albright
Acquire New Substrate PI Alpha 1 Antitrypsin
Protein Aggregation HTT Huntington Disease
Chimeric Gene BCR-ABL CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is HTT located?

A

4p16.3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Evidence that the CAG repeat expansion is a gain of function mutation includes:

A
  • deletions including HD fail to manifest HD
  • Phenotypically normal individuals with translocation breakpoint disrupting HTT
  • Homozygotes clinically identical to heterozygotes
  • The dominant phenotype suggests the mRNA or protein has acquired a new property or expressed inappropriately; HD levels of polypeptides encoded by normal and mutant allele are identical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the pathogenic events in HD

A

Polyglutamine expansions =neuronal intranuclear inclusions containing HTT, chaperone proteins and ubiquitin.
inclusions most frequently observed in the regions of brain showing particular sensitivity to the HD mutation and more abundant in brains of juvenile onset HD with large CAG repeat.
However, inclusions do not cause the disease themselves: mouse models and human brains, location of the inclusions does not always correlate with cell toxicity.
Mutant HTT = abnormal protein structures e.g. β-sheets -truncated by caspase-6 cleavage, = toxic N-terminal frags= processing of abnormal proteins (e.g. ubiquitin pathway) altered in HD.
The toxicity of HTT is affected by post-translational modification and nuclear localisation.
Mutant HTT interferes with gene transcription (PGC1α) and may effect mitochondria= affected metabolism and oxidative stress.
Abnormal vesicle transport with decreased transport/release of brain-derived neurotrophic factor (BDNF) and increased excitotoxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nature of expanded repeats in DM1 and DM2?

A

(CUG)n and (CCUG)n

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mechanism of parthenogenesis

A
  • Repeat expansions form stable structures that sequestrate RNA-binding proteins e.g. muscleblind-like (MBNL) and CUG-BP1 in ribonuclear inclusions.
  • Altered expression and activity of these RNA regulatory proteins affects alternative splicing e.g. downregulation of MBNL1, upregulation of CUG-BP1.
  • embryonic splicing patterns of several important genes observed instead of adult splicing e.g. CIC-1 chloride channel, insulin receptor, troponin T.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of Spinocerebellar ataxia caused by CAG polyglutamine expansions?

A

1, 2, 3, 6, 7, 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of SC8 pathogencity?

A

both RNA and protein gain of function
• Proposed bi-directional transcription at SCA8 locus ATXN8 antisense CAG-containing translated into ataxin 8 protein and found in intranuclear inclusions in Purkinje cells and in brainstem neurons of SCA8 patients
• concomitant expression of untranslated antisense CTG mutation in the 3’UTR of the ATXN8OS =CUG repeat transcript that becomes toxic via an RNA gain of function mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gene for Achondroplasia?

A

FGFR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is FGFR3?

A

transmembrane TK which negatively regulates bone growth by inhibiting the proliferation of chondrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pathogenic mechanism of Achondroplasia mutations?

A

constitutive activation of the FGF receptor= severely limiting bone growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Achondroplasia mutational spectrum

A

Two mutations account for >99% of achondroplasia

17
Q

novel fusion genes (in cancer) example

A

BCR-ABL1 t(9;22)(q34;q11)

18
Q

CML represents what % of paed and adult leukemia?

A

paed ~15% adult 80%

19
Q

how does the BCR-ABL fusion act?

A

as a onco gene promoting genomic instability.

Increased activity of TK.

20
Q

How many fusion transcripts can result from the BCR-ABL rearrangement?

A

four

(1) b2a2 mainly in CML
(2) b3a2 mainly in CML
(3) e1a2 mainly in ALL
(4) e19a2 rare-in CML

21
Q

Major role of PMP22?

A

major role in arresting Schwann cell division

22
Q

AD Over expression example

A

Hereditary motor and sensory neuropathy HMSN

23
Q

most common cause of CMT?

A

~80% 1.5Mb dup 17p12

24
Q

Other cause of CMT other than dup 17p12?

A

activating mutations

25
Q

What does PMP22 encode?

A

glycoprotein peripheral myelin protein-22.